Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis. Aliment Pharmacol Ther. 2022 02; 55(3):302-310.
View in:
PubMed
subject areas
Colitis, Ulcerative
Humans
Marketing
Piperidines
Pyrimidines
Pyrroles
authors with profiles
David T. Rubin